Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetWages, Salaries and Other
Ratios

Rhythm Pharmaceuticals (RYTM) Leases (2018 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Leases for 8 consecutive years, with $3.0 million as the latest value for Q4 2025.

  • Quarterly Leases fell 12.31% to $3.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.0 million through Dec 2025, down 12.31% year-over-year, with the annual reading at $3.0 million for FY2025, 12.31% down from the prior year.
  • Leases for Q4 2025 was $3.0 million at Rhythm Pharmaceuticals, down from $3.2 million in the prior quarter.
  • The five-year high for Leases was $3.7 million in Q2 2024, with the low at $670000.0 in Q1 2024.
  • Average Leases over 5 years is $2.0 million, with a median of $1.6 million recorded in 2021.
  • The sharpest move saw Leases plummeted 38.42% in 2024, then soared 402.54% in 2025.
  • Over 5 years, Leases stood at $1.5 million in 2021, then dropped by 22.34% to $1.2 million in 2022, then crashed by 33.93% to $781000.0 in 2023, then skyrocketed by 345.2% to $3.5 million in 2024, then fell by 12.31% to $3.0 million in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $3.0 million, $3.2 million, and $3.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.